Literature DB >> 23871640

The limitations and hidden gems of the epidemiology of primary biliary cirrhosis.

Mauro Podda1, Carlo Selmi, Ana Lleo, Luca Moroni, Pietro Invernizzi.   

Abstract

Epidemiology is expected to provide important clues to our understanding of the enigmatic etiopathogenesis of primary biliary cirrhosis (PBC). First, a systematic review of population based studies indicated a wide range in the yearly incidence (0.33-5.8/100.000) and point prevalence (1.91-40.2/100.000) rates. Though different ethnic representations may also contribute it is likely that methodological issues, based on the retrospective survey of diagnosed cases, and time trend play a major role, also in view of the prolonged asymptomatic period of the disease. Of note, the highest prevalence rates (35-40/100.000) were found in areas characterized by high medical awareness and easier access to healthcare. Second, the search for serum AMA in unselected population sera may identify the largest possible number of patients who have or will develop the disease. Indeed, a surprisingly high AMA prevalence rate, ranging between 0.43 and 1%, appears likely in the general population despite the lack of adequate work-up in most studies. Third, the median female to male ratio for PBC is classically accepted as 9-10:1 but is significantly lower for AMA prevalence (2.5:1), death certificates for PBC (4.3:1) and liver transplantation (6:1), thus suggesting that PBC in men may be underdiagnosed in early stages or manifest a more severe progression. Lastly, studies of both PBC and serum AMA prevalence among family members and monozygotic twins strongly support the role played by genetic factors in the etiopathogenesis of the disease. In conclusion, PBC epidemiology is far from being a closed case and the numerous open issues will be solved through a collaborative effort and powerful data mining tools.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Clinical epidemiology; Primary biliary cirrhosis

Mesh:

Substances:

Year:  2013        PMID: 23871640     DOI: 10.1016/j.jaut.2013.06.015

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  23 in total

1.  The challenge of treating orphan disease.

Authors:  Carlos Dias; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2014-12       Impact factor: 8.667

Review 2.  Primary biliary cirrhosis: From bench to bedside.

Authors:  Elias Kouroumalis; George Notas
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-08-06

3.  Race/Ethnicity and Insurance-Specific Disparities in In-Hospital Mortality Among Adults with Primary Biliary Cholangitis: Analysis of 2007-2014 National Inpatient Sample.

Authors:  Artin Galoosian; Courtney Hanlon; Michele Tana; Ramsey Cheung; Robert J Wong
Journal:  Dig Dis Sci       Date:  2019-09-05       Impact factor: 3.199

Review 4.  Implications of genome-wide association studies in novel therapeutics in primary biliary cirrhosis.

Authors:  Marco Carbone; Ana Lleo; Richard N Sandford; Pietro Invernizzi
Journal:  Eur J Immunol       Date:  2014-02-27       Impact factor: 5.532

5.  Trichloroethylene Exposure Reduces Liver Injury in a Mouse Model of Primary Biliary Cholangitis.

Authors:  Jessica L Ray; Anna K Kopec; Nikita Joshi; Holly Cline-Fedewa; Lawrence H Lash; Kurt J Williams; Patrick S Leung; M Eric Gershwin; James P Luyendyk
Journal:  Toxicol Sci       Date:  2017-04-01       Impact factor: 4.849

Review 6.  Autoimmunity in 2013.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

Review 7.  Extrahepatic autoimmune conditions associated with primary biliary cirrhosis.

Authors:  Annarosa Floreani; Irene Franceschet; Nora Cazzagon; Alice Spinazzè; Alessandra Buja; Patrizia Furlan; Vincenzo Baldo; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

Review 8.  The diagnosis of primary biliary cirrhosis.

Authors:  Christopher L Bowlus; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2014-01-11       Impact factor: 9.754

9.  Low incidence of primary biliary cirrhosis (PBC) in the first-degree relatives of PBC probands after 8 years of follow-up.

Authors:  Aliya F Gulamhusein; Brian D Juran; Elizabeth J Atkinson; Bryan McCauley; Erik Schlicht; Konstantinos N Lazaridis
Journal:  Liver Int       Date:  2016-04-28       Impact factor: 5.828

10.  Extrahepatic malignancies in primary biliary cirrhosis: a comparative study at two European centers.

Authors:  Annarosa Floreani; Alice Spinazzè; Llorenc Caballeria; Ana Reig; Nora Cazzagon; Irene Franceschet; Alessandra Buja; Patrizia Furlan; Kenichi Harada; Patrick Sc Leung; M Eric Gershwin; Albert Pares
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.